Friedreich’s Ataxia News Forums Forums Research, Science, and Trials Reata Pharmaceuticals – Omaveloxolone Update

  • Reata Pharmaceuticals – Omaveloxolone Update

    Posted by christina-cordaro on February 10, 2021 at 7:44 am

    Reata Pharmaceuticals, Chairman & CEO Warren Huff shares this response letter of appreciation to the FA Community.

    This letter is in response to FARA’s February 5th communication and submission of the FA Community Petition: Food & Drug Administration & Reata Pharmaceuticals: Allow Individuals with Friedreich Ataxia Access to Omaveloxolone.

    To read the letter, click below:
    bit.ly/3aS3vTs

    christina-cordaro replied 3 years, 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.